Literature DB >> 11104782

Unraveling the mechanism of action of thiazolidinediones.

C R Kahn1, L Chen, S E Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11104782      PMCID： PMC387251          DOI： 10.1172/JCI11705

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  25 in total

1.  Mechanism of insulin resistance in A-ZIP/F-1 fatless mice.

Authors:  J K Kim; O Gavrilova; Y Chen; M L Reitman; G I Shulman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 2.  Transcriptional regulation of adipogenesis.

Authors:  E D Rosen; C J Walkey; P Puigserver; B M Spiegelman
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

3.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

Authors:  O Gavrilova; B Marcus-Samuels; D Graham; J K Kim; G I Shulman; A L Castle; C Vinson; M Eckhaus; M L Reitman
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

4.  Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.

Authors:  R N Kulkarni; J C Brüning; J N Winnay; C Postic; M A Magnuson; C R Kahn
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

Review 5.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 6.  Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes.

Authors:  U Smith; M Axelsen; E Carvalho; B Eliasson; P A Jansson; C Wesslau
Journal:  Ann N Y Acad Sci       Date:  1999-11-18       Impact factor: 5.691

7.  Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.

Authors:  E Arioglu; J Duncan-Morin; N Sebring; K I Rother; N Gottlieb; J Lieberman; D Herion; D E Kleiner; J Reynolds; A Premkumar; A E Sumner; J Hoofnagle; M L Reitman; S I Taylor
Journal:  Ann Intern Med       Date:  2000-08-15       Impact factor: 25.391

8.  Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.

Authors:  M D Michael; R N Kulkarni; C Postic; S F Previs; G I Shulman; M A Magnuson; C R Kahn
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

9.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

10.  Life without white fat: a transgenic mouse.

Authors:  J Moitra; M M Mason; M Olive; D Krylov; O Gavrilova; B Marcus-Samuels; L Feigenbaum; E Lee; T Aoyama; M Eckhaus; M L Reitman; C Vinson
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361
View more
  45 in total

1.  Optic atrophy 1 is an A-kinase anchoring protein on lipid droplets that mediates adrenergic control of lipolysis.

Authors:  Guillaume Pidoux; Oliwia Witczak; Elisabeth Jarnæss; Linda Myrvold; Henning Urlaub; Anne Jorunn Stokka; Thomas Küntziger; Kjetil Taskén
Journal:  EMBO J       Date:  2011-10-07       Impact factor: 11.598

2.  PPARG regulates gonadotropin-releasing hormone signaling in LbetaT2 cells in vitro and pituitary gonadotroph function in vivo in mice.

Authors:  Shweta Sharma; Prem M Sharma; Devendra S Mistry; R Jeffery Chang; Jerrold M Olefsky; Pamela L Mellon; Nicholas J G Webster
Journal:  Biol Reprod       Date:  2010-11-10       Impact factor: 4.285

Review 3.  Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus.

Authors:  Helmut Walter; Georg Lübben
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Insulin resistance and improvements in signal transduction.

Authors:  Nicolas Musi; Laurie J Goodyear
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

5.  Pioglitazone therapy for HIV/HAART-associated lipodystrophy syndrome could increase subcutaneous fat mass in non-lipoatrophic but not in lipoatrophic regions.

Authors:  Sadanori Okada; Mitsuru Konishi; Hitoshi Ishii
Journal:  BMJ Case Rep       Date:  2016-02-25

Review 6.  Metabolic syndrome therapy: prevention of vascular injury by antidiabetic agents.

Authors:  Ligia J Dominguez; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

7.  Soy protein isolate inhibits high-fat diet-induced senescence pathways in osteoblasts to maintain bone acquisition in male rats.

Authors:  Jin-Ran Chen; Oxana P Lazarenko; Michael L Blackburn; Thomas M Badger; Martin J J Ronis
Journal:  Endocrinology       Date:  2014-12-09       Impact factor: 4.736

Review 8.  Emerging treatments for post-transplantation diabetes mellitus.

Authors:  Trond Jenssen; Anders Hartmann
Journal:  Nat Rev Nephrol       Date:  2015-04-28       Impact factor: 28.314

9.  A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia.

Authors:  D C Henderson; X Fan; B Sharma; P M Copeland; C P Borba; R Boxill; O Freudenreich; C Cather; A Eden Evins; D C Goff
Journal:  Acta Psychiatr Scand       Date:  2009-01-12       Impact factor: 6.392

10.  The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials.

Authors:  Siddharth H Sheth; Robin J Larson
Journal:  BMC Infect Dis       Date:  2010-06-23       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.